Evolent Health Earnings Estimate
| EVH Stock | USD 3.21 0.03 0.93% |
Evolent Health Earnings Estimation Breakdown
The calculation of Evolent Health's earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Evolent Health is estimated to be 0.07545 with the future projection ranging from a low of 0.045 to a high of 0.1202. Please be aware that this consensus of annual earnings estimates for Evolent Health is based on EPS before non-recurring items and includes expenses related to employee stock options.Last Reported EPS
0.04 Lowest | Expected EPS | 0.12 Highest |
Evolent Health Earnings Projection Consensus
Suppose the current estimates of Evolent Health's value are higher than the current market price of the Evolent Health stock. In this case, investors may conclude that Evolent Health is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Evolent Health's stock will quickly adjusts to the new information provided by the consensus estimate.
| Number of Analysts | Historical Accuracy | Last Reported EPS | Estimated EPS for 31st of December 2026 | Current EPS (TTM) | |
| 16 | 34.22% | 0.0 | 0.07545 | -1.57 |
Evolent Health Earnings per Share Projection vs Actual
Actual Earning per Share of Evolent Health refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering Evolent Health predict the company's earnings will be in the future. The higher the earnings per share of Evolent Health, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.Evolent Health Estimated Months Earnings per Share
For an investor who is primarily interested in generating an income out of investing in entities such as Evolent Health, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of Evolent Health should always be considered in relation to other companies to make a more educated investment decision.Evolent Quarterly Analyst Estimates and Surprise Metrics
Earnings surprises can significantly impact Evolent Health's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
null | null | null | null | null | 0 | ||
null | null | null | null | null | 0 | ||
2025-11-06 | 2025-09-30 | 0.11 | 0.05 | -0.06 | 54 | ||
2025-08-07 | 2025-06-30 | 0.08 | -0.1 | -0.18 | 225 | ||
2025-05-08 | 2025-03-31 | 0.1 | 0.06 | -0.04 | 40 | ||
2025-02-20 | 2024-12-31 | 0.0125 | -0.02 | -0.0325 | 260 | ||
2024-11-07 | 2024-09-30 | 0.34 | 0.04 | -0.3 | 88 | ||
2024-08-08 | 2024-06-30 | 0.25 | 0.3 | 0.05 | 20 | ||
2024-05-09 | 2024-03-31 | 0.24 | 0.34 | 0.1 | 41 | ||
2024-02-22 | 2023-12-31 | 0.15 | 0.23 | 0.08 | 53 | ||
2023-11-02 | 2023-09-30 | 0.07 | 0.3 | 0.23 | 328 | ||
2023-08-02 | 2023-06-30 | 0.11 | 0.14 | 0.03 | 27 | ||
2023-05-03 | 2023-03-31 | 0.2 | 0.21 | 0.01 | 5 | ||
2023-02-22 | 2022-12-31 | 0.16 | 0.1 | -0.06 | 37 | ||
2022-11-02 | 2022-09-30 | 0.12 | 0.59 | 0.47 | 391 | ||
2022-08-02 | 2022-06-30 | 0.05 | 0.1 | 0.05 | 100 | ||
2022-05-04 | 2022-03-31 | -0.002 | 0.12 | 0.122 | 6100 | ||
2022-02-23 | 2021-12-31 | 0.01 | 0.08 | 0.07 | 700 | ||
2021-11-03 | 2021-09-30 | -0.03 | -0.03 | 0.0 | 0 | ||
2021-08-04 | 2021-06-30 | -0.04 | -0.02 | 0.02 | 50 | ||
2021-05-05 | 2021-03-31 | -0.06 | -0.01 | 0.05 | 83 | ||
2021-02-25 | 2020-12-31 | -0.05 | -0.01 | 0.04 | 80 | ||
2020-11-05 | 2020-09-30 | -0.04 | -0.03 | 0.01 | 25 | ||
2020-08-04 | 2020-06-30 | -0.1 | -0.03 | 0.07 | 70 | ||
2020-05-07 | 2020-03-31 | -0.13 | -0.14 | -0.01 | 7 | ||
2020-02-25 | 2019-12-31 | -0.04 | -0.07 | -0.03 | 75 | ||
2019-11-05 | 2019-09-30 | -0.13 | -0.09 | 0.04 | 30 | ||
2019-08-06 | 2019-06-30 | -0.23 | -0.26 | -0.03 | 13 | ||
2019-05-07 | 2019-03-31 | -0.33 | -0.31 | 0.02 | 6 | ||
2019-02-26 | 2018-12-31 | -0.04 | -0.07 | -0.03 | 75 | ||
2018-11-06 | 2018-09-30 | -0.04 | -0.04 | 0.0 | 0 | ||
2018-08-07 | 2018-06-30 | -0.04 | -0.03 | 0.01 | 25 | ||
2018-05-09 | 2018-03-31 | -0.04 | 0.02 | 0.06 | 150 | ||
2018-02-27 | 2017-12-31 | -0.04 | -0.04 | 0.0 | 0 | ||
2017-11-02 | 2017-09-30 | -0.08 | -0.04 | 0.04 | 50 | ||
2017-08-07 | 2017-06-30 | -0.13 | -0.13 | 0.0 | 0 | ||
2017-05-09 | 2017-03-31 | -0.16 | -0.14 | 0.02 | 12 | ||
2017-02-28 | 2016-12-31 | -0.2 | -0.18 | 0.02 | 10 | ||
2016-11-09 | 2016-09-30 | -0.13 | -0.11 | 0.02 | 15 | ||
2016-08-04 | 2016-06-30 | -0.16 | -0.12 | 0.04 | 25 | ||
2016-05-12 | 2016-03-31 | -0.19 | -0.16 | 0.03 | 15 | ||
2016-02-25 | 2015-12-31 | -0.21 | -0.05 | 0.16 | 76 | ||
2015-11-05 | 2015-09-30 | -0.21 | -0.29 | -0.08 | 38 | ||
2015-08-07 | 2015-06-30 | -0.32 | -1.57 | -1.25 | 390 |
About Evolent Health Earnings Estimate
The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of Evolent Health earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current Evolent Health estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as Evolent Health fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.| Last Reported | Projected for Next Year | ||
| Retained Earnings | -702.7 M | -667.6 M | |
| Retained Earnings Total Equity | -545.5 M | -518.3 M | |
| Earnings Yield | (0.05) | (0.06) | |
| Price Earnings Ratio | (24.08) | (25.28) | |
| Price Earnings To Growth Ratio | 0.51 | 0.30 |
Currently Active Assets on Macroaxis
When determining whether Evolent Health offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Evolent Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Evolent Health Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Evolent Health Stock:Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Evolent Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. For more detail on how to invest in Evolent Stock please use our How to Invest in Evolent Health guide.You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Is there potential for Health Care Technology market expansion? Will Evolent introduce new products? Factors like these will boost the valuation of Evolent Health. Projected growth potential of Evolent fundamentally drives upward valuation adjustments. Understanding fair value requires weighing current performance against future potential. All the valuation information about Evolent Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.57) | Revenue Per Share | Quarterly Revenue Growth (0.23) | Return On Assets | Return On Equity |
Understanding Evolent Health requires distinguishing between market price and book value, where the latter reflects Evolent's accounting equity. The concept of intrinsic value—what Evolent Health's is actually worth based on fundamentals—guides informed investors toward better entry and exit points. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Market sentiment, economic cycles, and investor behavior can push Evolent Health's price substantially above or below its fundamental value.
It's important to distinguish between Evolent Health's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Evolent Health should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Evolent Health's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.